Saline
DrugPatients will take 1 ml of lidocaine 2%
NCT Number: NCT07445191
This study aims to clinically evaluate the efficacy of trigger points using active drug mix (Triamcinolone with lidocaine) on relief of myofascial pain of jaw muscle.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Phase 2 / Phase 3
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will take 1 ml of lidocaine 2%
Patients will take 1 ml of active drug mix (1/4 ml of Triamcinolone and 3/4 ml of lidocaine)
Patients will take 1 ml lidocaine 2%
Time frame: 1 week , 1 month , 3 months after treatment
Time frame: 1 week , 1 month , 3 months after treatment
Data will be collected preoperatively, pain will be measured immediately after the treatment, as well as one week, one month, and 3 months after the end of the treatment sessions
Time frame: 1 week , 1 month , 3 months after treatment
measuring unit number
Time frame: 1 week , 1 month , 3 months after treatment
measured by likert scale
Time frame: 1 week , 1 month , 3 months after treatment
measuresd by algometer
Contact information is provided by the study sponsor or research team.
Ammar Ali Mudhsh Al-Hawbani Ammar Ali Mudhsh Al-Hawbani, bachelor's degree
CONTACT
Hamida Refai Hasanien Hasanien professor, phd
CONTACT
Cairo University
Other
Clinical Assessment of The Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07536399
Oral and Maxillofacial Conditions, TMJ - Oral &Maxillofacial Surgery
New York, United States
View Trial DetailsNCT07511959
Craniomandibular Disorders, Jaw Diseases
Wroclaw, Poland
View Trial DetailsNCT07600203
TMD, TMJ
Acton, Massachusetts, United States
View Trial DetailsNCT07437924
Behavior, Bruxism
Konya, Turkey (Türkiye)
View Trial Details